Rivaroxaban in antiphospholipid syndrome (RAPS) protocol: a prospective, randomized controlled phase II/III clinical trial of rivaroxaban versus warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE

Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis

(2013) Sam Schulman et al.   CIRCULATION

Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism

(2013)   NEW ENGLAND JOURNAL OF MEDICINE

Oral Apixaban for the Treatment of Acute Venous Thromboembolism

(2013) Giancarlo Agnelli et al.   NEW ENGLAND JOURNAL OF MEDICINE

Estimated Frequency of Antiphospholipid Antibodies in Patients With Pregnancy Morbidity, Stroke, Myocardial Infarction, and Deep Vein Thrombosis: A Critical Review of the Literature

(2013) Laura Andreoli et al.   ARTHRITIS CARE & RESEARCH

Guidelines on the investigation and management of antiphospholipid syndrome

(2012) David Keeling et al.   BRITISH JOURNAL OF HAEMATOLOGY

Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism

(2012)   NEW ENGLAND JOURNAL OF MEDICINE

Apixaban for Extended Treatment of Venous Thromboembolism

(2012) Giancarlo Agnelli et al.   NEW ENGLAND JOURNAL OF MEDICINE

Guidelines on oral anticoagulation with warfarin - fourth edition

(2011) David Keeling et al.   BRITISH JOURNAL OF HAEMATOLOGY

Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate

(2011) Elise S. Eerenberg et al.   CIRCULATION

The clinical significance of differences between point-of-care and laboratory INR methods in over-anticoagulated patients

(2011) A.S. Lawrie et al.   THROMBOSIS RESEARCH

Factor X and factor II activity levels do not always agree in warfarin-treated lupus anticoagulant patients

(2010) Terry K Rosborough et al.   BLOOD COAGULATION & FIBRINOLYSIS

The impact of elective knee/hip replacement surgery and thromboprophylaxis with rivaroxaban or dalteparin on thrombin generation

(2010) Laura Green et al.   BRITISH JOURNAL OF HAEMATOLOGY

Antiphospholipid syndrome

(2010) Guillermo Ruiz-Irastorza et al.   LANCET

Oral Rivaroxaban for Symptomatic Venous Thromboembolism

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Assessment of laboratory assays to measure rivaroxaban – an oral, direct factor Xa inhibitor

(2010) Jean-Luc Martinoli et al.   THROMBOSIS AND HAEMOSTASIS

Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies

(2009) Maria G. Tektonidou et al.   ARTHRITIS AND RHEUMATISM

Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism

(2009) Sam Schulman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Standardisation of thrombin generation test - which reference plasma for TGT?: An international multicentre study

(2009) Y. Dargaud et al.   THROMBOSIS RESEARCH

Wide variation in thrombin generation in patients with atrial fibrillation and therapeutic International Normalized Ratio is not due to inflammation

(2008) A. Gatt et al.   BRITISH JOURNAL OF HAEMATOLOGY

Prediction of Recurrent Venous Thromboembolism by Endogenous Thrombin Potential and D-Dimer

(2008) S. Eichinger et al.   CLINICAL CHEMISTRY

Combination of D-dimer, F1+2 and residual vein obstruction as predictors of VTE recurrence in patients with first VTE episode after OAT withdrawal

(2008) D. POLI et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

High rate of unprovoked recurrent venous thrombosis is associated with high thrombin-generating potential in a prospective cohort study

(2008) M. BESSER et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Endogenous thrombin potential (ETP) in plasma from patients with AMI during antithrombotic treatment

(2008) E. Brodin et al.   THROMBOSIS RESEARCH